Product Theater:
Astrazeneca

WHEN: Sun, Oct 25 // 1:15 pm - 2:15 pm (ET)

IN-PERSON: Seaport Ballroom (Mezzanine / Level 2)
LIVESTREAM: TBD
ENDURING: TBD

New Data on ATTR-CM for Health Care Providers From CARDIO-TTRansformJoin an AstraZeneca- and Ionis-sponsored session presenting phase 3 trial results for an investigational treatment for transthyretin amyloid cardiomyopathy (ATTR-CM).

Speaker:

Jennifer White, DHSc, CCP, MS
Lexeo Therapeutics

BACK TO MAIN PRODUCT THEATERS PAGE